全文获取类型
收费全文 | 23348篇 |
免费 | 2596篇 |
国内免费 | 450篇 |
专业分类
耳鼻咽喉 | 172篇 |
儿科学 | 404篇 |
妇产科学 | 412篇 |
基础医学 | 1518篇 |
口腔科学 | 1244篇 |
临床医学 | 5399篇 |
内科学 | 3221篇 |
皮肤病学 | 328篇 |
神经病学 | 1246篇 |
特种医学 | 256篇 |
外国民族医学 | 1篇 |
外科学 | 2145篇 |
综合类 | 1772篇 |
一般理论 | 4篇 |
预防医学 | 2397篇 |
眼科学 | 287篇 |
药学 | 2309篇 |
15篇 | |
中国医学 | 1766篇 |
肿瘤学 | 1498篇 |
出版年
2024年 | 14篇 |
2023年 | 984篇 |
2022年 | 1119篇 |
2021年 | 1791篇 |
2020年 | 1966篇 |
2019年 | 1559篇 |
2018年 | 1335篇 |
2017年 | 1209篇 |
2016年 | 1185篇 |
2015年 | 972篇 |
2014年 | 1944篇 |
2013年 | 1912篇 |
2012年 | 1309篇 |
2011年 | 1477篇 |
2010年 | 1103篇 |
2009年 | 1012篇 |
2008年 | 976篇 |
2007年 | 851篇 |
2006年 | 826篇 |
2005年 | 632篇 |
2004年 | 477篇 |
2003年 | 412篇 |
2002年 | 272篇 |
2001年 | 228篇 |
2000年 | 149篇 |
1999年 | 101篇 |
1998年 | 77篇 |
1997年 | 71篇 |
1996年 | 65篇 |
1995年 | 53篇 |
1994年 | 46篇 |
1993年 | 33篇 |
1992年 | 29篇 |
1991年 | 27篇 |
1990年 | 15篇 |
1989年 | 23篇 |
1988年 | 26篇 |
1987年 | 12篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 16篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1977年 | 3篇 |
1976年 | 9篇 |
1975年 | 8篇 |
1970年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
背景 注意偏向矫正(ABM)是近年来情绪调节领域研究的热点之一,指通过计算机程序反复训练个体对中性或正性刺激的关注以达到纠正其对负性刺激的注意偏向、改善异常认知的过程。近年来,国内外公开发表的ABM治疗抑郁的文献报道逐年增多,但评价指标较为分散,相关循证证据不足。 目的 系统评价ABM疗法对抑郁患者的干预效果。 方法 计算机检索PubMed、The Cochrane Library、EMBase、中国生物医学文献数据库(CBMdisc)、中国知网(CNKI)、万方数据知识服务平台和维普网(VIP),搜集有关ABM治疗抑郁患者的随机对照试验(RCT),检索时限均为建库至2021-12-31。干预措施:试验组采用基于计算机的ABM治疗;对照组实施同等条件下的安慰训练,包括空白对照、假ABM刺激等。主要结局指标包括汉密尔顿抑郁评定量表(HAMD/HRSD)、贝克抑郁量表(BDI)和流行病学研究中心抑郁量表(CES-D)评分;次要结局指标包括状态-特质焦虑量表(STAI)、冗思反应量表(RRS)评分。由两位研究者独立筛选文献、提取资料,并采用Cochrane提供的偏倚风险评估工具2.0版本(RoB 2.0)进行偏倚风险评价,采用RevMan 5.4和Stata 12.0软件进行Meta分析。 结果 最终纳入13篇文献,其中1篇文献提取为2个试验报告,共包含968例患者。13篇文献均为RCT,其中7篇文献评价为低偏倚风险,4篇文献评价为中偏倚风险,2篇文献评价为高偏倚风险。Meta分析结果显示,试验组抑郁水平、焦虑情绪及冗思反应的改善优于对照组(P≤0.05);亚组分析:干预后随访时间<2个月时,试验组与对照组BDI-Ⅱ、HAMD评分比较,差异无统计学意义(P>0.05);干预后随访时间≥2个月时,试验组与对照组BDI-Ⅱ评分比较,差异无统计学意义(P>0.05)。 结论 ABM疗法能明显改善抑郁患者的抑郁、焦虑及冗思反应,但该疗法的长期疗效仍需进一步研究。 相似文献
3.
4.
目的 基于《国际功能、残疾和健康分类》(ICF)构建智力和发展性残疾儿童青少年身体活动效益系统综述的范畴和PICO架构,探讨智力和发展性残疾儿童和青少年参加身体活动的健康效益。 相似文献
5.
《中医科学杂志(英文)》2022,9(4):351-364
ObjectiveTo explore the protective effect and potential mechanisms of danshen root (Salvia miltiorrhiza Bge., S. miltiorrhiza) and its extracts for the treatment of diabetic nephropathy (DN).MethodsPreclinical studies of S. miltiorrhiza and its extracts on DN were systematically searched in nine databases. The primary outcomes were blood glucose, kidney function, proteinuria, and renal histopathology. The secondary outcomes included the related mechanisms. The methodological quality of animal studies was assessed based on the risk of bias tool of the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) for animal studies. Meta-analysis was performed using R software (version 4.1.2).ResultsTwenty-nine animal experimental studies that met the eligibility criteria were included in this study. Compared to the control group, S. miltiorrhiza reduced the serum creatinine, blood urea nitrogen, 24-h urine protein, 24-h urine albumin, blood glucose, and kidney index (kidney weight/body weight), and alleviated renal pathological damage. In terms of the mechanism of action, compared to the control group, S. miltiorrhiza reduced the levels of transforming growth factor β1, collagen IV, malondialdehyde, tumor necrosis factor α, interleukin-6, and monocyte/macrophage (ED-1), and increased the levels of superoxide dismutase, glutathione peroxidase, nuclear factor E2–related factor 2, and heme oxygenase-1.ConclusionThe existing evidence shows that S. miltiorrhiza has beneficial effects on the animal model of DN, and its mechanism is mainly related to improving kidney fibrosis, oxidative stress, and inflammatory response. 相似文献
6.
7.
摘要: 目的 系统评价注射用头孢哌酮钠/舒巴坦钠(商品名:舒普深)在中国治疗临床感染的有效性和安全性。 方法 系
统检索万方、中国知网、维普、SinoMed、PubMed和Cochrane Library数据库,收集1978年至2019年7月4日公开发表的关于头孢
哌酮/舒巴坦在中国治疗临床感染方面的文献,按照纳入排除标准进行筛选,使用Stata 15.0和SAS 9.4软件进行荟萃(Meta)分析。
主要结局指标包括临床有效率与痊愈率,次要结局指标包括细菌清除率(株)与不良事件发生率。 结果 最终纳入110篇文献,其
中有82篇、87篇分别纳入有效率和痊愈率的Meta分析。结果显示,头孢哌酮/舒巴坦治疗临床感染的总有效率为80.3% [95%置信
区间(CI): 77.4%~83.0%],痊愈率为50.1% (95%CI: 45.1%~55.1%)。共38项研究报告了细菌清除率,结果显示细菌清除率为81.1%
(95%CI: 76.9%~84.9%)。62篇文献报告治疗中发生的不良事件例数,合计不良事件的发生率为7.4% (95%CI: 6.1%~8.9%),包括
血液系统不良事件、胃肠道不良事件、肝肾功能损害及皮肤不良事件等。与其他对照药物相比,头孢哌酮/舒巴坦治疗临床感染
的有效性和安全性良好。 结论 头孢哌酮/舒巴坦的临床应用效果较为可观,对治疗临床感染具有较高的价值,安全性好。但
临床应注意合理用药,加强对头孢哌酮/舒巴坦的不良事件监测,减少不良事件。 相似文献
8.
9.
《International journal of oral and maxillofacial surgery》2022,51(2):234-242
The aim of this overview was to assess the methodological quality of systematic reviews of randomized clinical trials on alveolar ridge preservation after a tooth extraction. During March 2020, two independent reviewers performed an electronic search of the PubMed (MEDLINE), Scopus, Web of Science, and Cochrane Library databases to identify all relevant systematic reviews including randomized clinical trials on alveolar ridge preservation. A manual search of articles in renowned journals was also conducted. The methodological quality of the included reviews was determined using the AMSTAR-2 tool. From the 53 initially retrieved studies, 11 were finally included: three systematic reviews and eight systematic reviews with meta-analyses. The methodological quality of the included reviews was low or critically low. Higher quality clinical studies should be conducted prior to performing further reviews and these should meet the methodological requirements that are fundamental to this type of research. 相似文献
10.
《Journal of pediatric surgery》2023,58(9):1843-1848
BackgroundCommon salt is a safe, effective and cheap home-made remedy for umbilical granuloma. The aim of this scoping review is to identify and summarize the available evidence and examine the research conducted on salt treatment for umbilical granuloma.MethodsA literature search was performed in the second week of September, 2022 using Google scholar, PubMed, MEDLINE and EMBASE databases using the keywords ‘umbilical granuloma’ and ‘salt treatment’ to identify all English articles pertaining to salt treatment for umbilical granuloma. Tables were made to summarize the methodological characteristics, results and the dosage regimens of salt used by different authors. The Cochrane Collaboration's tool was used for assessing risk of bias in RCTs. The indexing statuses of the journals publishing these studies were also noted. The overall efficacy with the use of common salt was calculated by adding the success rates mentioned in each study.ResultsTwenty-four articles (2 systematic reviews, 6 Randomized Controlled Trials, 11 prospective cohort studies, 1 case control study, 3 retrospective case series and 1 case report) were included. An overall 93.91% success rate (1033/1100) was seen with common salt application, without any reports of complications/recurrences.ConclusionTopical application of common salt for umbilical granulomas is simple, effective and inexpensive. This scoping review provides a broader outlook at the existing level of evidence and may help in planning interventional comparative studies, so that recommendations can be formulated. It also highlights a lack of properly designed randomized controlled trials on this topic.Level of EvidenceI. 相似文献